Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

by · The Cerbat Gem

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the stock.

Milestone Scientific Stock Up 4.2 %

Shares of MLSS opened at $0.99 on Monday. Milestone Scientific has a 52-week low of $0.54 and a 52-week high of $1.39. The firm has a market cap of $77.11 million, a price-to-earnings ratio of -14.14 and a beta of 1.41. The business’s 50 day moving average is $1.09 and its two-hundred day moving average is $0.96.

Hedge Funds Weigh In On Milestone Scientific

A number of institutional investors and hedge funds have recently bought and sold shares of MLSS. World Investment Advisors LLC bought a new position in shares of Milestone Scientific in the third quarter valued at $91,000. Renaissance Technologies LLC raised its position in shares of Milestone Scientific by 72.8% during the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific during the third quarter valued at $48,000. Geode Capital Management LLC boosted its position in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Finally, Carnegie Investment Counsel increased its stake in Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares in the last quarter. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Read More